{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:37:53Z","timestamp":1772678273863,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health & Welfare","doi-asserted-by":"publisher","award":["A111550"],"award-info":[{"award-number":["A111550"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jmoldx.2015.12.002","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T15:53:06Z","timestamp":1457193186000},"page":"378-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21"],"prefix":"10.1016","volume":"18","author":[{"given":"Da Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyae","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Mee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2015.12.002_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ajog.2012.02.021","article-title":"Noninvasive prenatal testing for aneuploidy-ready for prime time?","volume":"206","author":"Chitty","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/14767058.2013.770464","article-title":"Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population","volume":"26","author":"Song","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pd.4101","article-title":"Commercial landscape of noninvasive prenatal testing in the United States","volume":"33","author":"Agarwal","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jpm-2011-0282","article-title":"Noninvasive prenatal diagnosis of Down syndrome: current knowledge and novel insights","volume":"40","author":"Sifakis","year":"2012","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1472-6483(10)60713-4","article-title":"Candidate epigenetic biomarkers for noninvasive prenatal diagnosis of Down syndrome","volume":"15","author":"Old","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2353\/ajpath.2009.081038","article-title":"Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies","volume":"174","author":"Papageorgiou","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pd.2335","article-title":"A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease","volume":"29","author":"Chu","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pd.1700","article-title":"Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast","volume":"27","author":"Alberry","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5468\/OGS.2013.56.2.58","article-title":"Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood","volume":"56","author":"Lim","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1373\/clinchem.2009.134114","article-title":"Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach","volume":"56","author":"Tong","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm.2312","article-title":"Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21","volume":"17","author":"Papageorgiou","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib15","doi-asserted-by":"crossref","first-page":"e27709","DOI":"10.1371\/journal.pone.0027709","article-title":"Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma","volume":"6","author":"Lim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib16","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-06-0376","article-title":"Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia","volume":"66","author":"Gebhard","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/epi.6.1.13313","article-title":"Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias","volume":"6","author":"Nair","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/nar\/gkp992","article-title":"MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome","volume":"38","author":"Serre","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1755-8794-5-26","article-title":"Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray","volume":"5","author":"Yin","year":"2012","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/cclm-2013-0802","article-title":"Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density","volume":"52","author":"Lim","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-8794-7-1","article-title":"Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21","volume":"7","author":"Lim","year":"2014","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib22","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1373\/clinchem.2006.074997","article-title":"Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis","volume":"52","author":"Chan","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pd.2546","article-title":"Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma","volume":"30","author":"Zhao","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib24","doi-asserted-by":"crossref","first-page":"e45073","DOI":"10.1371\/journal.pone.0045073","article-title":"Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis","volume":"7","author":"White","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib25","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/nar\/10.8.2709","article-title":"Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells","volume":"10","author":"Ehrlich","year":"1982","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib26","doi-asserted-by":"crossref","first-page":"c7401","DOI":"10.1136\/bmj.c7401","article-title":"Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study","volume":"342","author":"Chiu","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jmoldx.2015.12.002_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157816000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157816000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T18:07:18Z","timestamp":1600279638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157816000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1525157816000404"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.12.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}